The New York Entrepreneur

DexCom shares tumble nearly 40% after company cuts sales forecast

Read Time:14 Second

DexCom Inc., a maker of monitoring devices for diabetes patients, cut its full-year sales outlook on Thursday — a move that surprised some analysts and investors and sent its stock tumbling after hours — as the company deals with a shortfall in new patients and weaker trends abroad.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Previous post Paris Olympics offer a reset for sponsors after years of troubled games
Next post This real-estate ETF is trouncing S&P 500 in July with big gains